mas with similar frequency (29%, 36%, respectively). This retrospective analysis suggests that defects of humoral and/or CMI do not alone predict susceptibility to lymphoma or other cancer in A-T. Supported by USPHS CP-43384. Recent studies haveSunco;ered lmohocvte factor(s) caoable of enhancing erythropoiesis in vitro", he" in vivo significance of thfs finding remains unkn%nRecently a nine-year-old boy with ALL and replaced marrow (90% lynphoblasts) presented with a [Hgb.] of 11.9g/dl. Eighty-eight % of the patient's bone marrow cells reacted with antihuman T-cell monoclonal antibody (OKT3. pan). Sixty percent of the cells reacted with monoclonal antibody identifying helper cell function (OKT4. ind). 105 patientl.s T-lynphoblasts were co-cultured with 2 x lo5 normal marrow cells in methylcellulose and erythroid colonies (CFU-E) were counted. The T-lymphoblasts exerted a marked he1 per effect (+130%) on normal colony growth. The patient's plasma exerted no effect. Conditioned media derived from the T-lynphoblasts similarly stimulated normal erythropoiesis (+I 50%). During remission the patient's [Hgb.] dropped to 7 g/dl and his peripheral blood mononuclear cells exerted no helper effect upon normal CFU-F. During relapse concomitant with a rise in the number of blasts in the patient's bone marrow, the [Hgb.] rose steadily and reached a level of 13.4 g/dl preterminally. Repeat studies using the patient's peripheral blood mononuclear cells (87% Tlynphoblasts) again stimulated normal marrow CFU-E (+54%) We conclude that in this patient with T-ALL, the T-lymphoblasts exerted a stimulatory effect on eryt Iropoiesis helping to maintain the [Hgb.] The mechanism of anemia in pts with end-stage renal disease was studied by assessing erythroid colony growth in methylcellulose cultures. Peripheral blood BFU-E from 10 anemic PtS were normal when cultured in control serum (mean 22 BFU-El10 , range 14-41 vs control mean 18+10/10~), but declined a mean of 67% when autologous uremic serum was substituted. Sera from 53 of 60 pts cultured with control marrow produced a mean decrease in BFU-E of 74% and in CFU-E of 79%. The serum inhibition was confirmed by reproducing the effect on control marrow colony growth with specific fractions of pts' serum separated by sephacryl gel chromatography. Neither peritoneal dialysis nor hemodialysis reduced the inhibitory activity, but it disappeared with successful renal transplantation. Analysis of uremic serum revealed a striking increase in a ribonuclease of M.W. 33,000 in all pts (9,500-40,00Ou/ml vs control mean 1,047f247u/ml) that was'not eliminated by therapeutic dialysis. Purified ribonuclease produced dose-dependant inhibition of control marrow CFU-E but had unpredictable effects on BFU-E. We conclude that in anemic uremic pts: erythroid progenitors are adequate; the serum contains erythropoietic inhibitors; a ribonuclease is increased and appears to have a role in the erythropoietic suppression. Vaso-occlusive crises in SCD may compromise the blood flow of the inner ear. For this reason the incidence of peripheral hearing loss in patients with SCD may be greater than in the normal population. Forty-five patients with SCD, aged from four to nine teen years, were evaluated for peripheral and central auditory function. Results were compared with an age and race matched Routine audiometry and electroacoustic measurements of middle ear impedance were performed on all patients. Katzs' Staggered Spondaic Word test was achninistered to patients ten years of age and older to assess central auditory function. Mean hearing and acoustic reflex levels were well within normal limits for both groups. Eight of 33 patients (24 percent) on whom central auditory function was assessed showed various degrees of dysfunction. Two of these 8 patients previously had a cerebro-vascular accident.
This study is the first to suggest a significant degree of central auditory impairment in patients with SCD. It also reveals, contrary to previous studies, no greater incidence of either conductive or sensorineural hearing loss in these phtients Frequent CNS involvement in SCD is the possible cause of central auditory dysfunction.
New treatments are urgently needed for stage iV NB, which becomes resistant to chemotherapy (CT) in 75% of cases. We have treated 6 children (ch) wlth refractory NB with HD L-PAM, either 120 mg/m2 (4 ch) or 180 mg/m2 (2 ch), in 3 divided doses, followed by reinfusion of bone marrow (EM) previously frozen in l iquid N2 during EM remission. The ch were isolated during the neutro~enic phase and supported with red cells and platelets, and hyberalimentation vie.Broviac catheters. Toxicit : a,ll 6-recovered henpoiet ic function, in med Ian p e r i o d days (neutrophils 500), 34 days (retics I%), and 35 days (platelets 50,000). Gastrointestinal side effects were severe but short- 
